33 related articles for article (PubMed ID: 24665856)
1. Antiproliferative Effects of Epigenetic Modifier Drugs Through E-cadherin Up-regulation in Liver Cancer Cell Lines.
Uribe D; Cardona A; Esposti DD; Cros MP; Cuenin C; Herceg Z; Camargo M; Cortés-Mancera FM
Ann Hepatol; 2018; 17(3):444-460. PubMed ID: 29735783
[TBL] [Abstract][Full Text] [Related]
2. Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia.
Moskalev EA; Luckert K; Vorobjev IA; Mastitsky SE; Gladkikh AA; Stephan A; Schrenk M; Kaplanov KD; Kalashnikova OB; Pötz O; Joos TO; Hoheisel JD
BMC Cancer; 2012 Jun; 12():213. PubMed ID: 22672427
[TBL] [Abstract][Full Text] [Related]
3. Nephrotoxicity of epigenetic inhibitors used for the treatment of cancer.
Scholpa NE; Kolli RT; Moore M; Arnold RD; Glenn TC; Cummings BS
Chem Biol Interact; 2016 Oct; 258():21-9. PubMed ID: 27543423
[TBL] [Abstract][Full Text] [Related]
4. Oncopig bladder cancer cells recapitulate human bladder cancer treatment responses
Segatto NV; Simões LD; Bender CB; Sousa FS; Oliveira TL; Paschoal JDF; Pacheco BS; Lopes I; Seixas FK; Qazi A; Thomas FM; Chaki S; Robertson N; Newsom J; Patel S; Rund LA; Jordan LR; Bolt C; Schachtschneider KM; Schook LB; Collares TV
Front Oncol; 2024; 14():1323422. PubMed ID: 38469237
[TBL] [Abstract][Full Text] [Related]
5. DNA Methylation as a Therapeutic Target for Bladder Cancer.
Nunes SP; Henrique R; Jerónimo C; Paramio JM
Cells; 2020 Aug; 9(8):. PubMed ID: 32784599
[TBL] [Abstract][Full Text] [Related]
6. Silencing of CARMA3 inhibits bladder cancer cell migration and invasion via deactivating β-catenin signaling pathway.
Man X; Liu T; Jiang Y; Zhang Z; Zhu Y; Li Z; Kong C; He J
Onco Targets Ther; 2019; 12():6309-6322. PubMed ID: 31496734
[TBL] [Abstract][Full Text] [Related]
7. The effect of heat shock protein 90 inhibitors on histone 4 lysine 20 methylation in bladder cancer.
Coban N; Varol N
EXCLI J; 2019; 18():195-203. PubMed ID: 31217782
[TBL] [Abstract][Full Text] [Related]
8. Targeting DNA Methyltranferases in Urological Tumors.
Marques-Magalhães Â; Graça I; Henrique R; Jerónimo C
Front Pharmacol; 2018; 9():366. PubMed ID: 29706891
[TBL] [Abstract][Full Text] [Related]
9. Regulation of metastasis of bladder cancer cells through the WNT signaling pathway.
Du Y; Wang Y; Zhang F; Wu W; Wang W; Li H; Xia S; Liu H
Tumour Biol; 2015 Nov; 36(11):8839-44. PubMed ID: 26069102
[TBL] [Abstract][Full Text] [Related]
10. Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review.
Chiurillo MA
World J Exp Med; 2015 May; 5(2):84-102. PubMed ID: 25992323
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the cytotoxicity of cladribine and clofarabine when combined with fludarabine and busulfan in AML cells: Enhancement of cytotoxicity with epigenetic modulators.
Valdez BC; Li Y; Murray D; Ji J; Liu Y; Popat U; Champlin RE; Andersson BS
Exp Hematol; 2015 Jun; 43(6):448-61.e2. PubMed ID: 25704054
[TBL] [Abstract][Full Text] [Related]
12. Does Wnt/β-catenin pathway contribute to the stability of DNMT1 expression in urological cancer cell lines?
Varol N; Konac E; Bilen CY
Exp Biol Med (Maywood); 2015 May; 240(5):624-30. PubMed ID: 25349215
[TBL] [Abstract][Full Text] [Related]
13. The epigenetically regulated effects of Wnt antagonists on the expression of genes in the apoptosis pathway in human bladder cancer cell line (T24).
Varol N; Konac E; Onen IH; Gurocak S; Alp E; Yilmaz A; Menevse S; Sozen S
DNA Cell Biol; 2014 Jul; 33(7):408-17. PubMed ID: 24665856
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
[TBL] [Abstract][Full Text] [Related]
15. DNA methyltransferase inhibitor-mediated apoptosis in the Wnt/β-catenin signal pathway in a renal cell carcinoma cell line.
Konac E; Varol N; Yilmaz A; Menevse S; Sozen S
Exp Biol Med (Maywood); 2013 Sep; 238(9):1009-16. PubMed ID: 23975733
[TBL] [Abstract][Full Text] [Related]
16. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
17. Wnt signaling pathway in non-small cell lung cancer.
Stewart DJ
J Natl Cancer Inst; 2014 Jan; 106(1):djt356. PubMed ID: 24309006
[TBL] [Abstract][Full Text] [Related]
18. Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression.
Camilli TC; Weeraratna AT
Biochem Pharmacol; 2010 Sep; 80(5):702-11. PubMed ID: 20211149
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]